AIMS: Visfatin (NAMPT/PBEF) is a recently identified adipocytokine which harbors strong insulin-mimetic activity and was reported to be associated with obesity. However, nothing is known about whether visfatin is related to specific nutritional behavior which may result in obesity development. This is the first study focusing on genetic variability of the visfatin gene and its association with circulating visfatin, anthropometric parameters and dietary composition. MATERIALS AND METHODS: We analyzed a total of 11 exons and adjacent non-coding regions of the NAMPT gene in 20 extremely obese Czech individuals (mean BMI 52.2±5.0 SD) using direct sequencing and a frequency of rs2302559 was established in the validation cohort of another 605 individuals with completed 7-day food records and complex anthropometric measurements. Serum levels of visfatin, leptin and leptin-receptor were measured in all sequenced individuals and in part of the validation cohort. RESULTS: Three common polymorphisms were identified, two in non-coding regions (rs78411774 A/C, rs71564769 A/C) and one synonymous SNP in exon 7 (rs2302559 A/G). The rs2302559 showed significant correlation with visfatin serum level throughout the entire study cohort (p<0.001); there was a significant tendency toward higher visfatin levels in G allele carriers with GG homozygotes having the highest visfatin serum levels. Furthermore, a negative correlation was observed between visfatin and leptin serum level (p=0.01). No association between investigated SNPs and anthropometric parameters or native dietary composition was observed. CONCLUSION: This is the first study to demonstrate that the rs2302559 polymorphism in the PBEF gene is related to circulating levels of visfatin. As the SNP is synonymous, we hypothesize it might be linked to another SNP in the PBEF gene which controls visfatin serum levels.

Department of Pathological Physiology Faculty of Medicine Masaryk University Kamenice 5 Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc14064034

003      

CZ-PrNML

005      

20140708105320.0

007      

ta

008      

140704s2013 ne f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.dsx.2013.06.001 $2 doi

035    __

$a (PubMed)23953183

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Stastny, Jiri $u Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, Brno, Czech Republic.

245    10

$a Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population / $c J. Stastny, J. Bienertova-Vasku, J. Tomandl, M. Tomandlova, F. Zlamal, M. Forejt, Z. Splichal, A. Vasku,

520    9_

$a AIMS: Visfatin (NAMPT/PBEF) is a recently identified adipocytokine which harbors strong insulin-mimetic activity and was reported to be associated with obesity. However, nothing is known about whether visfatin is related to specific nutritional behavior which may result in obesity development. This is the first study focusing on genetic variability of the visfatin gene and its association with circulating visfatin, anthropometric parameters and dietary composition. MATERIALS AND METHODS: We analyzed a total of 11 exons and adjacent non-coding regions of the NAMPT gene in 20 extremely obese Czech individuals (mean BMI 52.2±5.0 SD) using direct sequencing and a frequency of rs2302559 was established in the validation cohort of another 605 individuals with completed 7-day food records and complex anthropometric measurements. Serum levels of visfatin, leptin and leptin-receptor were measured in all sequenced individuals and in part of the validation cohort. RESULTS: Three common polymorphisms were identified, two in non-coding regions (rs78411774 A/C, rs71564769 A/C) and one synonymous SNP in exon 7 (rs2302559 A/G). The rs2302559 showed significant correlation with visfatin serum level throughout the entire study cohort (p<0.001); there was a significant tendency toward higher visfatin levels in G allele carriers with GG homozygotes having the highest visfatin serum levels. Furthermore, a negative correlation was observed between visfatin and leptin serum level (p=0.01). No association between investigated SNPs and anthropometric parameters or native dietary composition was observed. CONCLUSION: This is the first study to demonstrate that the rs2302559 polymorphism in the PBEF gene is related to circulating levels of visfatin. As the SNP is synonymous, we hypothesize it might be linked to another SNP in the PBEF gene which controls visfatin serum levels.

650    _2

$a antropometrie $7 D000886

650    _2

$a krevní glukóza $x metabolismus $7 D001786

650    _2

$a index tělesné hmotnosti $7 D015992

650    _2

$a cytokiny $x genetika $x metabolismus $7 D016207

650    12

$a dieta $7 D004032

650    _2

$a dietní záznamy $7 D015930

650    _2

$a běloši $x genetika $7 D044465

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a nikotinamidfosforibosyltransferasa $x genetika $x metabolismus $7 D054409

650    _2

$a obezita $x epidemiologie $x genetika $x metabolismus $7 D009765

650    12

$a jednonukleotidový polymorfismus $7 D020641

650    _2

$a sekvenční analýza $7 D017421

650    _2

$a hubenost $7 D013851

651    _2

$a Česká republika $x epidemiologie $7 D018153

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

655    _2

$a validační studie $7 D023361

700    1_

$a Bienertova-Vasku, Julie

700    1_

$a Tomandl, Josef

700    1_

$a Tomandlova, Marie

700    1_

$a Zlamal, Filip

700    1_

$a Forejt, Martin

700    1_

$a Splichal, Zbynek

700    1_

$a Vasku, Anna

773    0_

$w MED00166706 $t Diabetes & metabolic syndrome $x 1878-0334 $g Roč. 7, č. 3 (2013), s. 166-71

856    41

$u https://pubmed.ncbi.nlm.nih.gov/23953183 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20140704 $b ABA008

991    __

$a 20140708105610 $b ABA008

999    __

$a ok $b bmc $g 1031518 $s 862766

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2013 $b 7 $c 3 $d 166-71 $i 1878-0334 $m Diabetes & metabolic syndrome $n Diabetes Metab Syndr $x MED00166706

LZP    __

$a Pubmed-20140704